RE:RE:ADD BIO new purchase price of $3.3 m , 33m unitsI think if someone digs deep enough into this add bio acquisition they may find A . Ryu's name and if SCRN management chooses not to be transperent about this questionable acquisition I will keep believing it . I am not insinuating that anything would be wrong about that but what is wrong is that close to half of the market cap of SCRN belongs to nameless might be could be breast cancer exam not even approved by HC and FDA recipient . Those upcoming financials better be stellar or else this sp will see a .003 pre consolidation . Brutal !! Ms. Kozovski has a mountain to climb .